)
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
VMukti Solutions has developed a device that can transmit high-quality videos using bandwidth aggregation technology
Majority gram sabhas pass resolution to oppose SIR status to the area where Maruti's proposed unit is to come up
Real estate arm of Mahindra Group is keen to set up integrated business city there
Fall after January-February recovery to continue
With Ju-C, the beverage maker launches a price war in the fruit juice space
The base variants of the Enjoy has be strategically priced at Rs 49,000 and Rs 70,000 cheaper than the Ertiga for petrol and diesel variants respectively
Entry of new players like Ford and Maruti Suzuki in Gujarat has encouraged the component manufacturers in the state
Global biosimilars market likely to touch $10 billion by 2015, India's share is 3%
Net sales were up 11% to Rs 378.36 crore as against Rs 342.30 crore in the year before period
The company plans to launch some two to three more products in the coming months
An increase of 5-8% expected in other regions, too; other dairies to follow suit
Bot infected computer activities can be classified as actively attacking bots or bots that send out spam such as spam zombies
Company ready with the product, but waiting for market conditions to improve to launch new product
As low-calorie space gains traction, ice cream maker launches new product
It is the only other segment, besides utility vehicles, showing growth prospects this year; expected to clock 5-6% growth
Members of IDMA to meet Pharmexcil representatives next week to finalise details
Apart from UVs, only other segment showing growth potential this year; expected to clock 5-6% growth